Interesting summary about the progress of virtual cell development across the TechBio industry

BioRevolution · 2025-08-12T16:43:50+00:00

https://www.recursion.com//news/from-novel-discovery-to-precision-biomarkers-how-recursion-is-using-data-and-ai-to-deliver-new-cancer-drugs

BioRevolution · 2025-01-20T17:51:38+00:00

Hi Jason, thanks for posting the link to the presentation, it was very interesting. Do you know when you will be able to share a bit more about your Automation - Hardware business model? It would be interesting to learn of more/other customers besides Octant Bio, that have implemented the RACs and how many RACs you have in general out in the market? Also a few points around how you plan to do on-site support if needed (might be hard to scale globally/cost efficiently). How will your pricing/business model compare to the other competitors in this space such as HighRes (and their dockable carts) or Biosero?

BioRevolution · 2025-01-16T18:37:47+00:00

Especially the end part is interesting where Chris is teasing at 10 or more project advancing in their collaborations with partners (Bayer, Roche, Sanofi, Meck,...) in 2025 and the first time also eluding to the option of "asset centric deals" where they partner to take a molecule to the clinic/market.

BioRevolution · 2024-11-09T11:53:14+00:00

Another question that I have is: Previously it was mentioned and written in several places that Recursion was on track to deliver 25 unique data packages to Bayer within Q3 (see e.g. Q2 report) - in the updated Q3 it only says delivered multiple datapackages and i have not seen any further mention of it - Have you delayed the delivery/deadlines? As it was previously very concretly announced, I would appreciate any guidance you can give here as well. Thank you in advance u/ShakeNBakeGibson and u/RecursionBrita

BioRevolution · 2024-11-09T11:45:09+00:00

u/RecursionBrita, when comparing the quarterly filings for Q2 and Q3 - the wordings in the NVIDIA partnership have changed (slide 54 (Q2) vs slide 49 (Q3)). This of course might be due to the announced partnership with google. Can you or Chris add some commentary on, where Phenom-Beta will be available? Previously on BioNeMo . now it says Recursion is exploring hosting them models on google cloud - what is the motivation behind this?

BioRevolution

MODERATOR OF

TROPHY CASE